Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a publicly traded biotechnology company dedicated to developing innovative biologics that address unmet medical needs. The companyâs core focus is on cell and exosome-based therapies, with a lead program targeting Duchenne muscular dystrophy through a proprietary cell therapy. Leveraging cuttingâedge exosome engineering, Capricor also explores treatments for rare and infectious diseases, supported by strong academic collaborations that drive a translational research pipeline. Its combination of advanced delivery platforms, diseaseâspecific expertise, and a robust partnership ecosystem distinguishes Capricor as a forwardâthinking player in the biopharma landscape.
Capricor Therapeutics is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. The Quality Control Associate III, Sample Management role is responsible for the receipt, tracking, storage, distribution, and disposal of samples in a controlled laboratory or regulated environment.
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a publicly traded biotechnology company dedicated to developing innovative biologics that address unmet medical needs. The companyâs core focus is on cell and exosome-based therapies, with a lead program targeting Duchenne muscular dystrophy through a proprietary cell therapy. Leveraging cuttingâedge exosome engineering, Capricor also explores treatments for rare and infectious diseases, supported by strong academic collaborations that drive a translational research pipeline. Its combination of advanced delivery platforms, diseaseâspecific expertise, and a robust partnership ecosystem distinguishes Capricor as a forwardâthinking player in the biopharma landscape.
Capricor Therapeutics, Inc.